Sulfasalazine (Blenheim Pharmacal, Inc.)
Welcome to the PulseAid listing for the Sulfasalazine drug offered from Blenheim Pharmacal, Inc.. This Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Blenheim Pharmacal, Inc. |
NON-PROPRIETARY NAME: | sulfasalazine |
SUBSTANCE NAME: | SULFASALAZINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-11-18 |
END MARKETING DATE: | 0000-00-00 |
Sulfasalazine HUMAN PRESCRIPTION DRUG Details:
Item Description | Sulfasalazine from Blenheim Pharmacal, Inc. |
LABELER NAME: | Blenheim Pharmacal, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2013-11-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10544-288_0ff320ac-60e2-4b75-e054-00144ff88e88 |
PRODUCT NDC: | 10544-288 |
APPLICATION NUMBER: | ANDA040349 |
Other SULFASALAZINE Pharmaceutical Manufacturers / Labelers: